Written by Ben Stevens and Sarah Sinclair.
You may learn Half 1 right here.
Rising demand for medical hashish throughout Europe
Medical hashish demand throughout Europe has seen substantial progress, notably following the regulatory adjustments in Germany.
Ukraine’s Well being Minister, Viktor Liashko, visited Germany this 12 months as a part of his preparations for medical hashish legalisation in his nation. The primary cannabis-based medicines are anticipated to be obtainable from subsequent 12 months.
“We hosted visits from politicians throughout celebration strains who needed to study hashish’s results, qc for hashish merchandise, and the way we’ve responded to the surging demand with extra workers and our revolutionary automation processes,” Fritsch explains.
Whereas the adoption of wider regulatory frameworks has seemingly stalled in France and Spain, Denmark is ready to undertake its medical hashish pilot program into everlasting laws.
Elsewhere, as of April 2025, an extra 5,000 GPs within the Czech Republic can be permitted to prescribe medical hashish, a transfer that’s anticipated to considerably enhance entry and enhance affected person numbers.
Worldwide corporations are additionally taking an curiosity out there and scaling up manufacturing to satisfy demand, in line with Cannaviga. With corporations in Thailand more and more trying to export merchandise to Europe, Sebastian Sonntagbauer, Head of Buyer Success at Cannavigia highlighted the significance of making certain they can meet stringent European requirements.
“As rules evolve globally, making certain that our shoppers can adapt rapidly is vital,” he says. “Our position is to supply ongoing help to allow them to give attention to progress whereas staying compliant.”
UK to give attention to high quality assurance and constructing affected person belief
The UK hashish market has seen continued progress all through 2024, however some recommend it is likely to be reaching a ‘essential crossroads’ by way of product high quality and compliance.
Matt Clifton, head of communications for Dalgety, warned that contamination points corresponding to mould, partly pushed by a requirement for non-irradiated merchandise, dangers ‘eroding sufferers’ belief’ out there.
“This shift towards high quality assurance isn’t nearly affected person care; it’s about rebuilding credibility and belief within the sector,” says Clifton.
“Whereas value pressures might entice short-term customers, this method is unsustainable and dangers eroding the business’s credibility. Corporations investing in larger requirements—like these holding GMP licenses—will seize rising market share as discerning sufferers go for security and consistency over affordability.”
After the MHRA moved to forestall the usage of pressure names on medical hashish flower merchandise this 12 months, Clifton additionally expects to see the regulator tightening the controls within the business over the subsequent 12 months.
“I consider the MHRA will count on the importer to re-test the merchandise coming into the UK,” he provides. “They already needs to be doing this, however I feel they are going to count on a larger degree of verification, not solely counting on the LPs knowledge.”
In the meantime, Adam Windish, of British Hashish Medical, highlighted that the implementation of e-prescribing, which was permitted by the MHRA this 12 months, would ‘considerably cut back affected person ready instances, streamline the method, and encourage extra individuals within the UK to think about medical hashish as a therapy choice’.
“Collaboration between healthcare professionals, sufferers, and suppliers is vital,” he says. “By persevering with to give attention to innovation, training, and accessibility throughout the UK market, I’m assured that we’ll see actual progress within the business.”
Rising product tendencies: extracts, edibles and personalised medicines
Because the market matures, it’s prone to see a gradual enlargement in product classes, together with extra demand for edibles and extracts and a shift away from flower.
Pastille lozenges and vape cartridges are already obtainable within the UK, though flower stays by far essentially the most generally prescribed product kind. Windish is hoping to see extra docs utilising oils and extracts, notably for cannabis-naive sufferers, to supply a “extra balanced and efficient hybrid therapy method.”
In different European markets, Demecan’s previewed its edible product at ExpoPharm earlier this 12 months, whereas in Luxembourg regulators are planning to limit entry to flower containing excessive ranges of THC, with a view to section this out solely in favour of oils.
Fritsch believes we’ll see a shift to extra personalised hashish medicines over the approaching 12 months. The corporate is making ready to supply custom-mixed extract concentrations and different types of consumption, corresponding to particular hashish concentrates.
Future analysis will discover the consequences of medical hashish on particular diagnoses, long-term therapeutic outcomes, healthcare value financial savings, and variations between supply strategies like extracts and capsules. Its analysis crew additionally highlighted some great benefits of glass containers over plastic for hashish storage.
Innovation in manufacturing processes
The gradual enlargement of product classes will even require extra revolutionary manufacturing processes.
Rebecca Allen-Tapp, Product Supervisor at Paralab Inexperienced, which gives cultivation gear, has seen a rise in corporations adopting automation and in-house options which provide “larger flexibility, enabling producers to streamline processes.”.
“Investing in versatile gear positions companies to adapt as market demand continues to develop and diversify,” she says.
“Gear corresponding to automated cartridge and vial fillers, NIR spectroscopy for nutrient monitoring, and qPCR techniques for early pathogen detection present important worth, bringing many beforehand outsourced duties in-house.”
With rising issues round irradiation, Allen-Tapp additionally reviews demand for different decontamination strategies, corresponding to cryopasteurization. And as ‘small-batch, craft-style hashish’ carves out a singular area of interest out there, there may be excessive demand for gear tailor-made to “smaller manufacturing volumes that ship precision and consistency.”
